{"id":"W2595416856","doi":"10.1200/jco.2007.25.18_suppl.7522","title":"Randomized phase II study of maintenance vandetanib (ZD6474) in small cell lung cancer (SCLC) patients who have a complete or partial response to induction therapy: NCIC CTG BR.20","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Niagara Health System; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Vandetanib; Gastroenterology; Hazard ratio; Asymptomatic; Progressive disease; Rash; Maintenance therapy; Performance status; Progression-free survival; Surgery; Chemotherapy; Confidence interval; Sorafenib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01817601,0.0002336838,0.003240435,0.0004281678,0.00008407966,0.000007700549,0.0002592372,0.0002479456,0.0001260799],"category_scores_gemma":[0.0125022,0.000141481,0.0004225094,0.0004030394,0.0003211856,0.00009952229,0.0001534925,0.001295447,0.000001855727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007445125,"about_ca_system_score_gemma":0.001887991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003336916,"about_ca_topic_score_gemma":0.002890357,"domain_scores_codex":[0.9918267,0.00263775,0.003902974,0.0003448027,0.0007506687,0.0005370955],"domain_scores_gemma":[0.9893786,0.006504321,0.002032748,0.0002742959,0.001332119,0.000477892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8659206,0.01178932,0.07819413,0.00004319346,0.000717424,0.0006465126,0.004121094,0.00005616137,0.0008913939,0.000001183664,0.002379717,0.03523928],"study_design_scores_gemma":[0.6857319,0.07969607,0.2205739,0.0003470349,0.0003736808,0.00002012702,0.001478733,0.0002486999,0.0002923422,0.00001867825,0.01106661,0.0001522082],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914394,0.0006650064,0.0002302262,0.003782772,0.001032222,0.002638422,0.00001130706,0.000007005143,0.0001936203],"genre_scores_gemma":[0.9956244,0.001176504,0.0003883264,0.001285945,0.0007384089,0.00006666078,0.000001102464,0.00002699266,0.0006916312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1801887,"threshold_uncertainty_score":0.9958159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1979454474880691,"score_gpt":0.5368576189100606,"score_spread":0.3389121714219914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}